Newman Dignan & Sheerar Inc’s Gilead Sciences GILD Stock Holding History

Newman Dignan & Sheerar Inc’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-3,150	Closed	-$226K	–	150
2016 Q4	$226K	Sell	3,150 -1,167	-27%	-$86.7K	0.14%	134
2016 Q3	$342K	Sell	4,317 -960	-18%	-$78K	0.22%	106
2016 Q2	$440K	Sell	5,277 -1,756	-25%	-$156K	0.27%	96
2016 Q1	$646K	Sell	7,033 -2,704	-28%	-$244K	0.47%	61
2015 Q4	$985K	Sell	9,737 -151	-2%	-$15.7K	0.7%	43
2015 Q3	$971K	Sell	9,888 -594	-6%	-$66K	0.62%	37
2015 Q2	$1.23M	Buy	10,482 +526	+5%	+$57.5K	0.88%	34
2015 Q1	$977K	Buy	9,956 +1,280	+15%	+$130K	0.7%	46
2014 Q4	$818	Buy	8,676 +51	+0.6%	+$5.28K	0.49%	54
2014 Q3	$918K	Buy	8,625 +1,598	+23%	+$156K	0.69%	45
2014 Q2	$583	Buy	+7,027	New	+$547K	0.33%	73

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Newman Dignan & Sheerar Inc's GILD Position: Q1 2017 in Review

Newman Dignan & Sheerar Inc sold out of Gilead Sciences (GILD) in Q1 2017, closing a stake of 3,150 shares — an estimated $226K sold.

Newman Dignan & Sheerar Inc first reported a position in GILD in Q2 2014 and held it in 11 quarters. The position peaked at $1.23M in Q2 2015. 1,524 funds tracked by Wall St. Rank hold GILD as of Q1 2017.

Newman Dignan & Sheerar Inc reported no remaining Gilead Sciences position as of Q1 2017 after selling out during the quarter.
Newman Dignan & Sheerar Inc sold 3,150 Gilead Sciences shares in Q1 2017, an estimated $226K.
Newman Dignan & Sheerar Inc first reported a position in Gilead Sciences in Q2 2014 and held it in 11 quarters.
Newman Dignan & Sheerar Inc's Gilead Sciences position peaked at $1.23M in Q2 2015.
1,524 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2017.

Based on Newman Dignan & Sheerar Inc's 13F filing for Q1 2017, filed 11 Apr 2017.